No evidence of P. falciparum K13 artemisinin conferring mutations over a 24-year analysis in Coastal Kenya, but a near complete reversion to chloroquine wild type parasites

Dades bibliogràfiques
Autors principals:	Wamae, K, Okanda, D, Ndwiga, L, Osoti, V, Kimenyi, K, Abdi, A, Bejon, P, Sutherland, C, Ochola-Oyier, L
Format:	Journal article
Idioma:	English
Publicat:	American Society for Microbiology 2019

Maintenance of high temporal Plasmodium falciparum genetic diversity and complexity of infection in asymptomatic and symptomatic infections in Kilifi, Kenya from 2007 to 2018
per: Kimenyi, KM, et al.
Publicat: (2022)

Maintenance of high temporal Plasmodium falciparum genetic diversity and complexity of infection in asymptomatic and symptomatic infections in Kilifi, Kenya from 2007 to 2018
per: Kelvin M. Kimenyi, et al.
Publicat: (2022-06-01)

Understanding P. falciparum asymptomatic infections: a proposition for a transcriptomic approach
per: Kimenyi, KM, et al.
Publicat: (2019)

The Plasmodium falciparum Rh5 invasion protein complex reveals an excess of rare variant mutations
per: Ndwiga, L, et al.
Publicat: (2021)

A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa
per: Ndwiga, L, et al.
Publicat: (2021)

Amplicon sequencing as a potential surveillance tool for complexity of infection and drug resistance markers in Plasmodium falciparum asymptomatic infections
per: Wamae, K, et al.
Publicat: (2022)

Low frequency of Plasmodium falciparum hrp2/3 deletions from symptomatic infections at a primary healthcare facility in Kilifi, Kenya
per: Dorcas Okanda, et al.
Publicat: (2023-02-01)

Understanding P. falciparum Asymptomatic Infections: A Proposition for a Transcriptomic Approach
per: Kelvin M. Kimenyi, et al.
Publicat: (2019-10-01)

Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya
per: Osoti, V, et al.
Publicat: (2025)

A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa
per: Leonard Ndwiga, et al.
Publicat: (2021-08-01)

Targeted amplicon deep sequencing for monitoring antimalarial resistance markers in western Kenya
per: Osoti, V, et al.
Publicat: (2022)

The Plasmodium falciparum Rh5 invasion protein complex reveals an excess of rare variant mutations
per: Leonard Ndwiga, et al.
Publicat: (2021-06-01)

A cross-sectional analysis identifies a low prevalence of Plasmodium ovale species infections in symptomatic and asymptomatic individuals in Kilifi county, Kenya. [version 4; peer review: 2 approved]
per: Leonard Ndwiga, et al.
Publicat: (2024-09-01)

Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya
per: Victor Osoti, et al.
Publicat: (2025-01-01)

ONT sequencing identifies a high prevalence of crt sensitive, triple mutant dhfr and single mutant dhps parasites within an ANC population in Nigeria
per: Adebanjo Jonathan Adegbola, et al.
Publicat: (2024-10-01)

Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya.
per: Okombo, J, et al.
Publicat: (2014)

No Plasmodium falciparum Chloroquine Resistance Transporter and Artemisinin Resistance Mutations, Haiti
per: Jeanne P. Vincent, et al.
Publicat: (2018-11-01)

Geographic-genetic analysis of Plasmodium falciparum parasite populations from surveys of primary school children in Western Kenya
per: Omedo, I, et al.
Publicat: (2017)

Transmission and age impact the risk of developing febrile malaria in children with asymptomatic Plasmodium falciparum parasitemia
per: Wamae, K, et al.
Publicat: (2018)

Chloroquine-Resistant Haplotype Plasmodium falciparum Parasites, Haiti
per: Berlin L. Londono, et al.
Publicat: (2009-05-01)

Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial [version 4; peer review: 2 approved, 2 approved with reservations]
per: Mainga Hamaluba, et al.
Publicat: (2024-03-01)

Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial [version 3; peer review: 2 approved, 2 approved with reservations]
per: Mainga Hamaluba, et al.
Publicat: (2023-10-01)

Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial [version 2; peer review: 2 approved, 1 approved with reservations]
per: Mainga Hamaluba, et al.
Publicat: (2022-12-01)

Artemisinin resistance and stage dependency of parasite clearance in Falciparum malaria
per: Intharabut, B, et al.
Publicat: (2019)

Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil
per: JP Dean Goldring, et al.
Publicat: (1999-09-01)

The timing of action of artemisinin on the malaria parasite, plasmodium falciparum
per: Desa, Nurul Wahida Md
Publicat: (2016)

New haplotypes of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene among chloroquine-resistant parasite isolates.
per: Nagesha, H, et al.
Publicat: (2003)

Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya
per: John Okombo, et al.
Publicat: (2014-12-01)

Few Plasmodium falciparum merozoite ligand and erythrocyte receptor pairs show evidence of balancing selection
per: Ochola-Oyier, L, et al.
Publicat: (2019)

The MSPDBL2 codon 591 polymorphism is associated with lumefantrine in vitro drug responses in Plasmodium falciparum isolates from Kilifi, Kenya.
per: Ochola-Oyier, L, et al.
Publicat: (2014)

Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in Kenya
per: Borrmann, S, et al.
Publicat: (2013)

Molecular analysis demonstrates high prevalence of chloroquine resistance but no evidence of artemisinin resistance in Plasmodium falciparum in the Chittagong Hill Tracts of Bangladesh.
per: Alam, MS, et al.
Publicat: (2017)

Geographic-genetic analysis of Plasmodium falciparum parasite populations from surveys of primary school children in Western Kenya [version 2; referees: 2 approved]
per: Irene Omedo, et al.
Publicat: (2017-09-01)

Lack of significant recovery of chloroquine sensitivity in Plasmodium falciparum parasites following discontinuance of chloroquine use in Papua New Guinea
per: Makoto Sekihara, et al.
Publicat: (2018-11-01)

In vitro drug interaction of ionophores with artemisinin and chloroquine against Plasmodium falciparum 3D7 blood-stage infection
per: Vinoth Rajendran, et al.
Publicat: (2023-11-01)

The mechanism of artemisinin resistance of Plasmodium falciparum malaria parasites originates in their initial transcriptional response
per: Zhu, L, et al.
Publicat: (2021)

Artemisinin resistant falciparum malaria in Myanmar
per: Tun, K
Publicat: (2015)

Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
per: Das, D, et al.
Publicat: (2013)

A Study of Synergy of Combination of Eosin B with Chloroquine, Artemisinin, and Sulphadoxine-Pyrimethamine on Plasmodium falciparum In Vitro and Plasmodium berghei In Vivo
per: Sedigheh Sadeghi, et al.
Publicat: (2020-01-01)

Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam
per: Nguyen Chinh Phong, et al.
Publicat: (2019-01-01)

No evidence of P. falciparum K13 artemisinin conferring mutations over a 24-year analysis in Coastal Kenya, but a near complete reversion to chloroquine wild type parasites

Ítems similars

Ítems similars